Estcourt et al., 2005 - Google Patents
Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responsesEstcourt et al., 2005
View PDF- Document ID
- 10538047742798124707
- Author
- Estcourt M
- Létourneau S
- McMichael A
- Hanke T
- Publication year
- Publication venue
- European journal of immunology
External Links
Snippet
The dynamics of primary CD8+ T cell responses following administration of modified virus Ankara (MVA)‐and DNA‐vectored vaccines was investigated in a mouse model. To overcome the low frequency of naive antigen‐specific precursors and follow the early …
- 229960005486 vaccines 0 title abstract description 64
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Estcourt et al. | Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses | |
| US8728485B2 (en) | Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome | |
| Allen et al. | Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen | |
| Nabel | Challenges and opportunities for development of an AIDS vaccine | |
| US12023377B2 (en) | Vaccine for use in the prophylaxis and/or treatment of a disease | |
| ES2638577T3 (en) | Adenoviral vectors encoding a pathogen or tumor antigen | |
| Wu et al. | Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens | |
| Cohen et al. | Novel HIV vaccine strategies: overview and perspective | |
| Bansal et al. | Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration | |
| Excler et al. | Novel directions in HIV-1 vaccines revealed from clinical trials | |
| Lema et al. | HIV vaccines: A brief overview | |
| Vasconcelos et al. | Relevance of long-lived CD8+ T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination | |
| EA037583B1 (en) | Methods and compositions for inducing protective immunity against human immunodeficiency virus infection | |
| Tatsis et al. | Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing | |
| JP2019162120A (en) | Poxvirus-plasmodium recombinants, compositions containing such recombinants, uses thereof, and methods of making and using the same | |
| Ondondo et al. | Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice | |
| Feng et al. | Induction of CD8+ T‐lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus | |
| Boyer et al. | DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication | |
| Roshorm et al. | T cells induced by recombinant chimpanzee adenovirus alone and in prime‐boost regimens decrease chimeric E co HIV/NDK challenge virus load | |
| McKee et al. | Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector | |
| Roshorm et al. | Novel HIV‐1 clade B candidate vaccines designed for HLA‐B* 5101+ patients protected mice against chimaeric ecotropic HIV‐1 challenge | |
| WO2005047483A2 (en) | Renta: an hiv immunogen and uses thereof | |
| Estcourt et al. | Altered primary CD8+ T cell response to a modified virus Ankara (MVA)‐vectored vaccine in the absence of CD4+ T cell help | |
| Überla | Efficacy of AIDS vaccine strategies in nonhuman primates | |
| Ravanfar et al. | HIV vaccines under study |